Source:http://linkedlifedata.com/resource/pubmed/id/18291705
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2008-6-20
|
pubmed:abstractText |
Chemokines binding the CXCR3 receptor have been shown to inhibit angiogenesis via the CXCR3-B isoform, but the underlying molecular mechanisms are unknown. Aim of this study was to elucidate the effects of CXCR3-B on activation of members of the mitogen-activated protein kinase family, and to explore the relevance of defined signaling pathways to the angiostatic effects of CXCR3-B ligands. Human embryonic kidney (HEK) 293 cells were transfected with expression vectors encoding for CXCR3-A or CXCR3-B. In cells expressing CXCR3-A, CXCL10 (IP-10) at nanomolar concentrations induced activation of ERK, Akt, and Src, as previously described in human vascular pericytes. In HEK-293 cells expressing CXCR3-B, exposure to CXCL10 in the micromolar concentration range led to activation of the p38(MAPK) pathway, as indicated by phosphorylation of p38(MAPK) itself, and of MKK3/6 and MAPKAPK-2, that lie upstream and downstream of p38(MAPK), respectively. Similar results were obtained in cells stimulated with CXCL4 (PF4), a specific ligand of CXCR3-B. In contrast, CXCL4 was unable to activate p38(MAPK) in mock-transfected HEK-293 cells. Only a modest induction of ERK or JNK was observed upon CXCR3-B activation. In human microvascular endothelial cells, which selectively express CXCR3-B, in a cell cycle-dependent fashion, CXCL10 and CXCL4 increased the enzymatic activity of p38(MAPK). Pharmacologic inhibition of p38(MAPK) by SB302580 resulted in a significant increase in DNA synthesis and in reversal of the inhibitory action of CXCL10. In conclusion, the p38(MAPK) pathway is a downstream effector of CXCR3-B implicated in the angiostatic action of this chemokine receptor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiostatic Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/CXCL10 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CXCR3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL10,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Factor 4,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR3,
http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1357-2725
|
pubmed:author |
pubmed-author:AnnunziatoFrancescoF,
pubmed-author:CosmiLorenzoL,
pubmed-author:LasagniLauraL,
pubmed-author:MarraFabioF,
pubmed-author:MazzinghiBenedettaB,
pubmed-author:PetraiIlariaI,
pubmed-author:PinzaniMassimoM,
pubmed-author:RomagnaniPaolaP,
pubmed-author:RomagnaniSergioS,
pubmed-author:RomanelliRoberto GRG,
pubmed-author:RomboutsKristaK,
pubmed-author:SagrinatiCostanzaC
|
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1764-74
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18291705-Angiostatic Proteins,
pubmed-meshheading:18291705-Cell Line,
pubmed-meshheading:18291705-Chemokine CXCL10,
pubmed-meshheading:18291705-Enzyme Activation,
pubmed-meshheading:18291705-Gene Expression Regulation,
pubmed-meshheading:18291705-Humans,
pubmed-meshheading:18291705-Platelet Factor 4,
pubmed-meshheading:18291705-Protein Isoforms,
pubmed-meshheading:18291705-Receptors, CXCR3,
pubmed-meshheading:18291705-Signal Transduction,
pubmed-meshheading:18291705-p38 Mitogen-Activated Protein Kinases
|
pubmed:year |
2008
|
pubmed:articleTitle |
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B.
|
pubmed:affiliation |
Dipartimento di Medicina Interna, University of Florence, Viale Morgagni 85, I-50134 Florence, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|